These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 680462)

  • 1. Correlation of differences in antigenicity of four 3-methyl-cholanthrene-induced tumors in syngeneic mice with the susceptibility of tumors to an immunopotentiator, PS-K.
    Abe S; Yamazaki M; Mizuno D
    Gan; 1978 Apr; 69(2):223-8. PubMed ID: 680462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of tumor-associated transplantation antigens of sublines of methylcholanthrene-induced murine tumors passaged separately in vivo for over a decade.
    Hines DL
    Cancer Res; 1986 Oct; 46(10):4921-6. PubMed ID: 3489516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effect of protein-bound polysaccharide preparation, PS-K, against 3-methylcholanthrene-induced fibrosarcoma in C57BL/6 mice.
    Ohno R; Imai K; Yokomaku S; Yamada K
    Gan; 1975 Dec; 66(6):679-81. PubMed ID: 131730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
    Fortner GW; Kripke ML
    J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor immunity after surgical removal of 3-methylcholanthrene-induced murine tumors: correlation between resistance and delayed hypersensitivity reaction.
    Abe S; Yamazaki M; Mizuno D
    Gan; 1978 Jun; 69(3):323-9. PubMed ID: 78867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic effects of an immunopotentiator, PS-K, on 3-methylcholanthrene-induced autochthonous tumors in C57BL/6 mice in combination with the surgical removal of primary sites.
    Hosokawa M; Mizukoshi T; Morikawa K; Xu ZY; Kobayashi H
    Cancer Immunol Immunother; 1986; 22(3):181-5. PubMed ID: 3731203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal thymectomy and tumor induction with methylcholanthrene in mice.
    Balner H; Dersjant H
    J Natl Cancer Inst; 1966 Mar; 36(3):513-21. PubMed ID: 18630325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of tumor immunogenicity to concentration of the oncogen.
    Prehn RT
    J Natl Cancer Inst; 1975 Jul; 55(1):189-90. PubMed ID: 1159812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated growth of syngeneic tumors in mice treated with methylcholanthrene.
    Lill PH; Jessup JM; Kripke ML
    Int J Cancer; 1978 Apr; 21(4):511-5. PubMed ID: 669850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further studies on cross-immunity among syngeneic tumors in mice.
    Usubuchi I; Nishimura S; Kudo H; Ito I; Sobajima Y
    Tohoku J Exp Med; 1975 Aug; 116(4):373-77. PubMed ID: 1188921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of syngeneic sensitized lymphoid cells on incidence and growth of methyl cholanthrene-induced and spontaneous tumors in mice.
    Gautam S; Aikat BK
    Indian J Med Res; 1976 Mar; 64(3):494-503. PubMed ID: 965050
    [No Abstract]   [Full Text] [Related]  

  • 12. Demonstration in vitro of cytotoxic T cells with apparent specificity toward tumor-specific transplantation antigens on chemically induced tumors.
    Chauvenet PH; McArthur CP; Smith RT
    J Immunol; 1979 Dec; 123(6):2575-81. PubMed ID: 315425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of the splenic cells of tumor-bearing mice on the allograft immune response].
    Spasokukotskiĭ AL
    Vopr Onkol; 1985; 31(7):87-91. PubMed ID: 4024565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of suppressor cells by syngeneic tumor transplants in mice.
    Argyris BF
    Cancer Res; 1978 May; 38(5):1269-73. PubMed ID: 147732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Coombs-positive reactions in mice during transplantation of syngeneic tumors].
    Buntsevich AM; Mikheeva NV
    Biull Eksp Biol Med; 1983 May; 95(5):81-4. PubMed ID: 6850095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated immune response of in vitro sensitized lymphocytes to isogeneic methyl-cholanthrene-induced tumor cell lines.
    Warnatz H; Scheiffarth F
    Transplantation; 1974 Sep; 18(3):273-9. PubMed ID: 4417443
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative analysis of the sensitivity to natural killers and macrophages of 3-methylcholanthrene-induced tumors in mice].
    Viksler VKh; Iaroslavtseva OA; Lavroskiĭ VA
    Eksp Onkol; 1986; 8(6):36-40. PubMed ID: 3803287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
    Matsumoto T; Himeno K; Mitani M; Mori K; Miake S; Nomoto K
    J Clin Lab Immunol; 1986 Feb; 19(2):83-9. PubMed ID: 3083105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common tumor rejection antigens in methylcholanthrene-induced squamous cell carcinomas of mice detected by tumor protection and a radioisotopic footpad assay.
    Economou GC; Takelchi N; Boone CW
    Cancer Res; 1977 Jan; 37(1):37-41. PubMed ID: 63329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological resistance to growth of tumours in syngeneic multiparous mice.
    Chandradasa KD; Barnes RM
    Eur J Cancer (1965); 1979 May; 15(5):671-7. PubMed ID: 315873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.